Human Case of Swine Influenza A (H1N1) Triple Reassortant Virus Infection, Wisconsin by Newman, Alexandra P. et al.
DISPATCHES
1470  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 9, September 2008
Human Case of 





Alexandra P. Newman,1 Erik Reisdorf, 
Jeanne Beinemann, Timothy M. Uyeki, 
Amanda Balish, Bo Shu, Stephen Lindstrom, 
Jenna Achenbach, Catherine Smith, 
and Jeffrey P. Davis
Zoonotic infections with swine inﬂ  uenza A viruses are 
reported sporadically. Triple reassortant swine inﬂ  uenza 
viruses have been isolated from pigs in the United States 
since 1998. We report a human case of upper respiratory 
illness associated with swine inﬂ  uenza A (H1N1) triple reas-
sortant virus infection that occurred during 2005 following 
exposure to freshly killed pigs.  
H
uman infections with swine inﬂ  uenza A viruses occur 
sporadically in the United States and Canada (1–8). 
Triple reassortant swine inﬂ  uenza viruses (containing genes 
derived from human, swine, and avian inﬂ  uenza A viruses) 
have been isolated from swine in the United States since 
1998 (9,10), and human infections with swine reassortant 
viruses have been documented (11–13). We report a case 
of respiratory illness in an adolescent boy associated with 
swine inﬂ  uenza A (H1N1) triple reassortant virus infection. 
The Study
On December 7, 2005, a previously healthy 17-year-
old boy with no history of recent travel became ill; symp-
toms were headache, rhinorrhea, low back pain, and cough 
without fever. He had received inactivated inﬂ  uenza vac-
cine administered intramuscularly on November 11, 2005. 
During an outpatient clinic visit on December 8, 2005, a 
nasal wash specimen was obtained and tested positive for 
inﬂ  uenza A by rapid inﬂ  uenza diagnostic test (BinaxNow 
A&B, Binax, Inc., Scarborough, ME, USA). Results of a 
chest radiograph were normal. The patient’s symptoms re-
solved on December 10, 2005. The specimen was sent to 
the Wisconsin State Laboratory of Hygiene (WSLH), and 
an inﬂ  uenza A virus was isolated by shell vial tissue cell 
culture (MDCK cells, WSLH, Madison, WI, USA). Real-
time reverse transcription–PCR (rRT-PCR) was positive 
for inﬂ  uenza A virus but negative for human subtypes H1, 
H3, and Asian avian H5. At the Centers for Disease Control 
and Prevention (CDC), rRT-PCR testing of the shell vial 
viral culture material was positive for inﬂ  uenza A virus, but 
negative for human subtypes H1 and H3, as well as avian 
subtypes H5, H7, and H9. Complete genomic sequenc-
ing of the virus at CDC identiﬁ  ed it as a swine inﬂ  uenza 
A (H1N1) triple reassortant virus, A/Wisconsin/87/2005 
H1N1. 
Investigation by the Wisconsin Division of Pub-
lic Health and the Sheboygan County Division of Public 
Health showed that the patient had assisted his brother-in-
law in butchering pigs at a custom slaughterhouse 3 days 
before illness onset. Thirty-one swine were delivered to the 
facility that morning by a distributor who had acquired the 
animals from multiple sources. None of the pigs appeared 
ill. The patient helped hold and abduct the forelimbs of 1 
freshly killed pig while his brother-in-law eviscerated it. 
No facial or respiratory protection was worn during this 
procedure. A few chickens were housed at the slaughter-
house premises, but no poultry were slaughtered on site. 
The patient denied any other contact with swine, poul-
try, or other animals during the 7 days before becoming ill. 
Eight days before illness onset, the patient’s father obtained 
a live chicken that was kept in the home for 1 day before 
it was sacriﬁ  ced during a ritual ceremony. The patient was 
never within 10 feet of the chicken and did not attend the 
ceremony. None of the patient’s household members or 
any slaughterhouse employees reported illness during the 
2 weeks before or after the patient became ill. 
Paired serum specimens were obtained from the pa-
tient and 4 family members on December 13, 2005, and 
January 9, 2006. A single serum specimen was obtained 
from the patient’s brother-in-law on December 19, 2005. 
Serologic testing was conducted at CDC by a standard he-
magglutinin inhibition (HI) antibody assay and reference 
antisera against inﬂ  uenza A (H1), A (H3), B, and swine 
A (H1N1) viruses A/swine/Wisconsin/238/97, A/swine/
Wisconsin/NJ56371/99, A/swine/Minnesota/593/99, and 
A/Wisconsin/87/2005 (isolated from the patient). HI anti-
body testing was negative for inﬂ  uenza A (H1), A (H3), 
and swine subtype H1N1 on all serum specimens, but 1 
family member had evidence of a 4-fold rise in HI antibody 
titer to inﬂ  uenza B/Hong Kong/330/2001 (B/Victoria/2/87 
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lineage) virus, which suggested an acute inﬂ  uenza B virus 
infection. All serum samples were also tested by microneu-
tralization assay at CDC using the patient’s swine inﬂ  uenza 
A (H1N1) virus isolate and a human inﬂ  uenza A virus (A/
New Caledonia/20/99 H1N1). The patient’s serum speci-
mens demonstrated a 2-fold increase in neutralizing anti-
body titer against swine inﬂ  uenza A/Wisconsin/87/2005 
subtype H1N1 virus, but the level of neutralizing antibodies 
to A/New Caledonia/20/99 (H1N1) virus was unchanged in 
acute- and convalescent-phase serum specimens, which is 
consistent with his history of inﬂ  uenza vaccination in mid-
November 2005. 
Conclusions
We report a human case of swine inﬂ  uenza A (H1N1) 
triple reassortant virus infection in the United States. The 
case-patient experienced a mild and acute respiratory illness 
and recovered fully. Swine inﬂ  uenza A/Wisconsin/87/2005 
(H1N1) virus was isolated from an upper respiratory speci-
men obtained from the patient, and serologic testing sug-
gested, but was not diagnostic of, an immune response to 
acute infection. Epidemiologic investigation showed the 
patient had direct and close exposure to freshly killed pigs 
and their organs while assisting his brother-in-law in butch-
ering them. Although the pigs did not appear ill, the most 
plausible source of the patient’s swine inﬂ  uenza A virus 
infection was respiratory secretions of freshly killed pigs. 
Surveillance data suggest that triple reassortant sub-
type H1N1 viruses are the predominant genotype of sub-
type H1N1 viruses in North American pigs (14). Persons 
having direct contact with swine are at greatest risk of 
infection with swine inﬂ  uenza viruses (4–7,13), but such 
contact is not documented in all cases (7). Human-to-
human transmission of swine inﬂ  uenza virus is rare, but 
evidence suggests that it has occurred (1–3,7,8,13). Human 
illness caused by infection with swine inﬂ  uenza viruses is 
often indistinguishable clinically from infections caused by 
other inﬂ  uenza viruses (1,7,12,13); complications, includ-
ing pneumonia and death, have been documented (3,4,7). 
Asymptomatic infections in humans caused by swine in-
ﬂ  uenza viruses may occur (5,8,13) and therefore, the true 
frequency of swine-to-human inﬂ  uenza virus transmission 
is unknown (3,5–7). 
We were limited in assessing other possible swine in-
ﬂ  uenza A (H1N1) virus infections and in conﬁ  rming swine 
inﬂ  uenza in the pigs. Pigs delivered to the slaughterhouse 
the day of the patient’s exposure originated from multiple 
farms, but specimens were unavailable for testing due to 
delays during animal traceback. Our ﬁ  ndings suggest that 
microneutralization assay may be more sensitive than a 
standard HI assay in detecting human antibodies to swine 
inﬂ  uenza A viruses. Primers and probes for detection of 
human inﬂ  uenza A viral RNA by rRT-PCR identiﬁ  ed a 
nonhuman inﬂ  uenza A virus, triggering further analyses 
that speciﬁ  cally identiﬁ  ed the virus. We could not conﬁ  rm 
whether the patient’s inﬂ  uenza vaccination and high levels 
of vaccine-derived subtype H1N1 neutralizing antibody in-
ﬂ  uenced his relatively mild clinical course of illness. The 
patient did not have a 4-fold increase in neutralizing anti-
body titer to the swine inﬂ  uenza A (H1N1) virus isolated 
from his respiratory specimens, which would be more sug-
gestive of acute infection. Further studies are needed to un-
derstand the human immune response to infection caused 
by swine inﬂ  uenza A viruses and to interpret serologic test 
results. 
Human infections with novel inﬂ  uenza A subtype vi-
ruses are now nationally notiﬁ  able in the United States. 
Clinicians should inquire about exposure to animals (in-
cluding pigs) and visits to petting zoos and county fairs 
when evaluating patients with unexplained inﬂ  uenza-like 
illnesses (15). Ideally, joint animal health and public health 
investigations should be conducted promptly to identify 
and control the source of swine inﬂ  uenza. Investigations 
should attempt to speciﬁ  cally identify the virus in animals 
and persons; deﬁ  ne the scope and clinical spectrum of hu-
man illnesses, including appropriately timed collection of 
serum specimens from ill persons and exposed individuals; 
determine risk factors for human infection; and assess the 
potential for human-to-human transmission of swine inﬂ  u-
enza A viruses.  
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